Study Attribute | Value |
---|---|
CEBS Accession Number: | 002-02756-0003-0000-5 |
Chemical Name: | Pyridine |
CASRN: | 110-86-1 |
NTP Study Type: | Genetic Toxicology - Mammalian Cell Cytogenetics |
NTP Study ID: | 631306_SCE |
Study Result: | Not a Valid Test |
Activation | Trial | Trial Call |
---|---|---|
No Activation | 1 | Test Failure |
No Activation | 2 | Test Failure |
Induced Rat Liver S9 | 1_S9 | Test Failure |
Induced Rat Liver S9 | 2_S9 | Test Failure |
Induced Rat Liver S9 | 3_S9 | Test Failure |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Medium | 0 | 50 | 1048 | 503 | 0.480 | 10.06 | 25.8 | 0.000 |
Test Chemical | Pyridine | 977 | 50 | 1039 | 506 | 0.487 | 10.12 | 25.8 | 1.468 |
3260 | 0 | 0 | 0 | 0.000 | 0.00 | 25.8 | N/A | ||
Positive Control | Mitomycin-C | 0.0015 | 50 | 1051 | 683 | 0.650 | 13.66 | 25.8 | 35.398 |
Mitomycin-C | 0.01 | 5 | 104 | 177 | 1.702 | 35.40 | 25.8 | 254.596 | |
Trend: | 0.231 | ||||||||
Probability: | 0.408 |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Medium | 0 | 50 | 1044 | 474 | 0.454 | 9.48 | 25.8 | 0.000 |
Test Chemical | Pyridine | 2740 | 50 | 1043 | 600 | 0.575 | 12.00 | 35.8 | 26.704 |
3000 | 50 | 1033 | 574 | 0.556 | 11.48 | 35.8 | 22.387 | ||
3260 | 50 | 1043 | 672 | 0.644 | 13.44 | 35.8 | 41.908 | ||
Positive Control | Mitomycin-C | 0.0015 | 50 | 1038 | 710 | 0.684 | 14.20 | 25.8 | 50.655 |
Mitomycin-C | 0.01 | 5 | 105 | 183 | 1.743 | 36.60 | 25.8 | 283.870 | |
Trend: | 5.310 | ||||||||
Probability: | 0.000 |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Medium | 0 | 50 | 1043 | 554 | 0.531 | 11.08 | 25.8 | 0.000 |
Test Chemical | Pyridine | 3260 | 50 | 1043 | 523 | 0.501 | 10.46 | 25.8 | -5.596 |
9770 | 0 | 0 | 0 | 0.000 | 0.00 | 25.8 | N/A | ||
Positive Control | Cyclophosphamide | 0.4 | 50 | 1047 | 683 | 0.652 | 13.66 | 25.8 | 22.814 |
Cyclophosphamide | 2 | 5 | 104 | 201 | 1.933 | 40.20 | 25.8 | 263.862 | |
Trend: | -0.945 | ||||||||
Probability: | 0.828 |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Medium | 0 | 50 | 1045 | 489 | 0.468 | 9.78 | 25.8 | 0.000 |
Test Chemical | Pyridine | 5710 | 50 | 1048 | 597 | 0.570 | 11.94 | 25.8 | 21.736 |
6520 | 50 | 1038 | 579 | 0.558 | 11.58 | 25.8 | 19.203 | ||
7340 | 50 | 1045 | 576 | 0.551 | 11.52 | 25.8 | 17.791 | ||
8150 | 0 | 0 | 0 | 0.000 | 0.00 | 35.8 | N/A | ||
Positive Control | Cyclophosphamide | 0.4 | 50 | 1047 | 747 | 0.713 | 14.94 | 25.8 | 52.469 |
Cyclophosphamide | 2 | 5 | 102 | 205 | 2.010 | 41.00 | 25.8 | 329.498 | |
Trend: | 2.319 | ||||||||
Probability: | 0.010 |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Medium | 0 | 50 | 1044 | 514 | 0.492 | 10.28 | 25.5 | 0.000 |
Test Chemical | Pyridine | 7500 | 50 | 1041 | 555 | 0.533 | 11.10 | 30.5 | 8.288 |
7820 | 50 | 1039 | 585 | 0.563 | 11.70 | 30.5 | 14.361 | ||
8150 | 50 | 1045 | 623 | 0.596 | 12.46 | 30.5 | 21.090 | ||
Positive Control | Cyclophosphamide | 0.4 | 50 | 1043 | 696 | 0.667 | 13.92 | 25.5 | 35.538 |
Cyclophosphamide | 2 | 5 | 106 | 188 | 1.774 | 37.60 | 25.5 | 260.238 | |
Trend: | 3.338 | ||||||||
Probability: | 0.000 |